Ads
related to: pharmaceutical drug companies
Search results
Henrietta Lacks' family can proceed in lawsuit against pharmaceutical company - Maryland Daily...
The Daily Record· 5 days agoThe family of Henrietta Lacks can proceed in its lawsuit against a pharmaceutical company that...
Bayer: The pharmaceutical company behind Leverkusen's success - and its difficult past
New York Times· 6 days agoThis could be one of the great campaigns in European football history, but Leverkusen are unusual in...
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit - The Boston...
The Boston Globe· 4 days agoThe judgment was issued against Bristol Myers Squibb Company and three US-based subsidiaries of...
Cold chain storage and distribution for the pharmaceutical industry
Pharmaceutical Technology via Yahoo Finance· 7 days agoMany pharmaceutical drugs, medicines and speciality treatments are temperature-sensitive and require swift supply chains. Cold chain storage and distribution provides a reliable ...
Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending Stock
Zacks· 4 days agoFree Report) has been one of the most searched-for stocks on Zacks.com lately. Over the past month, shares of this biotechnology company have returned +17.9%, compared to ...
Is Madrigal Pharmaceuticals Stock a Buy?
The Motley Fool via AOL· 6 days agoSome believe it could generate peak sales of $5.5 billion, not bad for a company that's worth only $4.5 billion. However, Rezdiffra won't reach that...
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.
CBS News· 6 days agoDirect-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1...
Here is What to Know Beyond Why Recursion Pharmaceuticals, Inc. (RXRX) is a Trending Stock
Zacks via Yahoo Finance· 4 days agoRecursion Pharmaceuticals (RXRX) has been one of the stocks most watched by Zacks.com users lately....
Supernus Pharmaceuticals stock maintains Buy rating on SPN-817 phase II trial By Investing.com
Investing.com· 2 days agoOn Friday, Supernus Pharmaceuticals (NASDAQ:SUPN) sustained its Buy rating alongside a steady stock...
Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
Digital Journal· 5 days agoNEW YORK, NY / ACCESSWIRE / May 21, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through ...
